Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy-MedSci.cn

Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy

Ying, HG; Xu, J; Zhang, XZ; Liang, TB; Bai, XL

Liang, TB; Bai, XL (通讯作者)，Zhejiang Univ, Sch Med, Affiliated Hosp 1, Zhejiang Prov Key Lab Pancreat Dis, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.

EBIOMEDICINE, 2022; 79 ():

Abstract

Human endogenous retrovirus-H long terminal repeat-associating 2 (HHLA2) is a newly emerging immune checkpoint that belongs to B7 family. HHLA2 has a ......

Full Text Link